HUM

HUM

USD

Humana Inc. Common Stock

$231.800+1.210 (0.525%)

Real-time Price

Healthcare
Healthcare Plans
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$230.590

High

$232.085

Low

$227.760

Volume

1.51M

Company Fundamentals

Market Cap

28.0B

Industry

Healthcare Plans

Country

United States

Trading Stats

Avg Volume

1.76M

Exchange

NYQ

Currency

USD

52-Week Range

Low $212.45Current $231.800High $406.46

Related News

BusinessWire

Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age

Presenting sponsor of the National Senior Games announces the Humana Game Changer Class of 2025 As the presenting sponsor of the 2025 National Senior Games, leading health and well-being company Humana Inc. (NYSE:HUM)

View more
Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age
Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $273 to $268.

View more
Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $268
PR Newswire

New PPO Dental Plans More Competitive Against HMOs

DentalInsurance.com, the leader in dental insurance comparison shopping, has broadened its inventory of PPO dental plans offering high maximum...

View more
New PPO Dental Plans More Competitive Against HMOs
PR Newswire

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Humana Inc. ("Humana") (NASDAQ: HUM), resulting...

View more
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces the Investigation of Humana Inc. (NASDAQ: HUM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
Reuters

Wall Street's potential winners and losers from Trump's tax bill

As President Donald Trump's sweeping tax-cut and spending bill heads to the Senate, analysts examine how his broad-ranging policies could turn the fortunes of U.S. companies if the package is enacted as law.

View more
Wall Street's potential winners and losers from Trump's tax bill
Reuters

Humana to back curbs to Medicare Advantage billing practices, WSJ reports

Humana has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry, the Wall Street Journal reported, citing staffers and a document viewed by it.

Analyst Upgrades

Barclays Maintains Equal-Weight on Humana, Lowers Price Target to $273

Barclays analyst Andrew Mok maintains Humana with a Equal-Weight and lowers the price target from $322 to $273.